期刊文献+

Lentivirus-mediated RNA interference targeting the ObR gene in human breast cancer MCF-7 cells in a nude mouse xenograft model 被引量:6

Lentivirus-mediated RNA interference targeting the ObR gene in human breast cancer MCF-7 cells in a nude mouse xenograft model
原文传递
导出
摘要 Background There is a significant association between obesity and breast cancer, which is possibly due to the expression of leptin. Therefore, it is important to clarify the role of leptin/ObR (leptin receptor) signaling during the progression of human breast cancer. Methods Nude mice with xenografts of MCF-7 human breast cancer cells were administered recombinant human leptin subcutaneous via injection around the tumor site. Mice in the experimental group were intratumorally injected with ObR-RNAi-lentivirus, while negative control group mice were injected with the same dose of negative-lentivirus. Tumor size was blindly measured every other day, and mRNA and protein expression levels of ObR, estrogen receptor a (ERa), and vascular endothelial growth factor (VEGF) for each group were determined.Results Knockdown of ObR-treated xenografted nude mice with a high leptin microenvironment was successfully established. Local injection of ObR-RNAi-lentivirus significantly suppressed the established tumor growth in nude mice. ObR level was significantly lower in the experimental group than in the negative control group, while the amounts of ERα and VEGF expression were significantly lower in the leptin group than in the control group (P 〈0.01 for all).Conclusions Inhibition of leptin/ObR signaling is essential to breast cancer proliferation and possible crosstalk between ObR and ERa, and VEGF, and may lead to novel therapeutic treatments aiming at targeting ObR in breast cancers. Background There is a significant association between obesity and breast cancer, which is possibly due to the expression of leptin. Therefore, it is important to clarify the role of leptin/ObR (leptin receptor) signaling during the progression of human breast cancer. Methods Nude mice with xenografts of MCF-7 human breast cancer cells were administered recombinant human leptin subcutaneous via injection around the tumor site. Mice in the experimental group were intratumorally injected with ObR-RNAi-lentivirus, while negative control group mice were injected with the same dose of negative-lentivirus. Tumor size was blindly measured every other day, and mRNA and protein expression levels of ObR, estrogen receptor a (ERa), and vascular endothelial growth factor (VEGF) for each group were determined.Results Knockdown of ObR-treated xenografted nude mice with a high leptin microenvironment was successfully established. Local injection of ObR-RNAi-lentivirus significantly suppressed the established tumor growth in nude mice. ObR level was significantly lower in the experimental group than in the negative control group, while the amounts of ERα and VEGF expression were significantly lower in the leptin group than in the control group (P 〈0.01 for all).Conclusions Inhibition of leptin/ObR signaling is essential to breast cancer proliferation and possible crosstalk between ObR and ERa, and VEGF, and may lead to novel therapeutic treatments aiming at targeting ObR in breast cancers.
出处 《Chinese Medical Journal》 SCIE CAS CSCD 2012年第9期1563-1570,共8页 中华医学杂志(英文版)
基金 This study was supported by a grant from the National Natural Science Foundation of China (No. 30772121) and the Beijing Natural Science Foundation (No. 7092024).
关键词 RNA interference breast neoplasms xenografi model leptin receptor estrogen receptor α vascular endothelial growth factor RNA interference breast neoplasms xenografi model leptin receptor estrogen receptor α vascular endothelial growth factor
  • 相关文献

参考文献4

二级参考文献35

  • 1王殊,王杉,张嘉庆,乔新民,杨德启,佟富中,叶颖江,崔志荣.雌激素受体亚型在人乳腺癌的表达及意义[J].中华外科杂志,2004,42(13):792-794. 被引量:16
  • 2HAN Ding-fen,ZHOU Xin,HU Ming-bai,XIE Wei,MAO Zong-fu,CHEN Dong-e,LIU Fang,ZHENG Fang.Polymorphisms of estrogen-metabolizing genes and breast cancer risk: a multigenic study[J].Chinese Medical Journal,2005(18):1507-1516. 被引量:9
  • 3Garofalo C, Surmacz E. Leptin and cancer. J Cell Physiol 2006; 207: 12-22.
  • 4Surmacz E. Growth factor receptors as therapeutic targets: strategies to inhibit the insulin-like growth factor I receptor. Oncogene 2003; 22: 6589-6597.
  • 5Ishikawa M, Kitayama J, Nagawa H. Enhanced expression of leptin and lepfin receptor (Oh-R) in human breast cancer. Clin Cancer Res 2004; 10: 4325-4331.
  • 6Surmacz E. Obesity hormone leptin: a new target in breast cancer? Breast Cancer Res 2007; 9: 30l.
  • 7Boyd DB. Insulin and cancer. Integr Cancer Ther 2003; 2: 315-329.
  • 8Garofalo C, Koda M, Cascio S, Sulkowska M, Koda LK, Golaszewska J, et al. Increased expression of leptin and the leptin receptor as a marker of breast cancer progression: possible role of obesity-related stimuli. Clin Cancer Res 2006; 12: 1447-1453.
  • 9Hoda MR, Keely S J, Bertelsen LS, Junger WG Dharmasena D, Barrett KE. Leptin acts as a mitogenic and antiapoptotic factor for colonic cancer cells. Br J Surg 2007; 94: 346-354.
  • 10Hu X, Junejia SC, Maihle NJ, Cleary ME Leptin-a growth factor in normal and malignant breast ceils and for normal mammary gland development. J Natl Cancer Inst 2003; 95: 1171-1173.

共引文献26

同被引文献33

引证文献6

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部